UnitedHealth (NYSE: UNH) has hurdles to clear, but the bottom is in and a reversal is underway. Headwinds are easing, allowing the company to focus on what it does best: generating healthy cash flow from its insurance and industry-related services and paying its shareholders. The catalyst in late April was the company's Q1 2026 earnings release, which showed outperformance relative to consensus forecasts. Additionally, the company provided stronger guidance and reinstated share buybacks.
UnitedHealth put a hold on buybacks last year to focus on balance-sheet health and navigating uncertain conditions. The news in April is that at least $2 billion in buybacks will be completed this quarter, worth about 0.65% of the market, with shares trading near long-term lows.
